May lead to a 34 percent lower risk of overall mortality
By 2019 that number is expected to rise to 23 percent
'The best test is one that patients will actually use'
Announced at opening SNMMI plenary session
Patients report no changes in urinary or sexual function
PET and SPECT: the good, the bad and the future
Research earns 'SNMMI Image of the Year' award
Early results indicate reduced misplacement
For cervical, breast and prostate cancer research
First dedicated proton therapy center in Russia
May lead to development of new treatment drugs
The following are just some of the products and services on display at SNMMI 2016
70 percent of Americans don’t know what to do during an event
Supply and demand are key factors
It is more like a metamorphosis than a radical transformation
FDA approves two imaging agents
Center hopes to gain insight on better developing neurology and psychiatric treatments
Total cost of dementia worldwide was $818 billion in 2015
Health care information field is of interest
May help find better management therapies
Personalized medicine is becoming more than a buzz word
A familiar name for expecting parents
Actual patient outcomes not representative of staffers' culture perceptions
Cost-benefit differences vary widely
Only takes five minutes
'A total failure of the system, from top to bottom'
Over 2,000 patients participating in study in seven months
Connecting the pieces for a healthier population
A new metric to measure interoperability could drive innovation
Yields almost 20 percent more
5-year survival benefit
Will support research on impact of cancer treatment on heart disease
Two promising radiotracers are gaining ground
Identifies unique advantages in undeveloped markets
Better results than Tc-99m-MDP bone scans
HTMs hold their ground in an evolving health system
250,000 men per year may avoid unnecessary biopsies
Advancements in image-guided therapies are needed
American Nurses Association applauds move, others are more skeptical
Axumin is commercially available in U.S.
